Advance your academic career, collaborate globally, and expand your network— join now !

Prof. Chiung-Mei Chen

Share Link

Share

Information

Dr. Chiung-Mei Chen graduated from Taipei Medical College in 1987. She received training in movement disorders from the UCL Institute of Neurology, Queen Square, London, from 1994 to 1995 and obtained her Ph.D. degree in Molecular Genetics, University of Glasgow, U.K., in 2002. She is currently a professor and physician scientist in the Department of Neurology, Chang Gung Memorial Hospital, and the College of Medicine, Chang-Gung University, Taoyuan, Taiwan. Dr. Chen’s main clinical and academic interests include Parkinson’s disease, spinocerebellar atrophy, Huntington’s disease, other movement disorders, neurogenetics, and neuroinflammatory diseases. She has already published more than 150 papers on SCI and several papers in renowned journals. Her main research focuses on the genetics, biomarkers, pathogenesis, and therapeutics in polyglutamine diseases, Parkinson’s disease, and Alzheimer's disease and also on neuroinflammation in neurological diseases using clinical material and cell and mouse models.

Short Biography

Dr. Chiung-Mei Chen graduated from Taipei Medical College in 1987. She received training in movement disorders from the UCL Institute of Neurology, Queen Square, London, from 1994 to 1995 and obtained her Ph.D. degree in Molecular Genetics, University of Glasgow, U.K., in 2002. She is currently a professor and physician scientist in the Department of Neurology, Chang Gung Memorial Hospital, and the College of Medicine, Chang-Gung University, Taoyuan, Taiwan. Dr. Chen’s main clinical and academic interests include Parkinson’s disease, spinocerebellar atrophy, Huntington’s disease, other movement disorders, neurogenetics, and neuroinflammatory diseases. She has already published more than 150 papers on SCI and several papers in renowned journals. Her main research focuses on the genetics, biomarkers, pathogenesis, and therapeutics in polyglutamine diseases, Parkinson’s disease, and Alzheimer's disease and also on neuroinflammation in neurological diseases using clinical material and cell and mouse models.